Literature DB >> 2594050

Comparative study of four antifungal drugs in an experimental model of murine cryptococcosis.

A J Bava1, C Iovannitti, R Negroni.   

Abstract

A comparative study among amphotericin B, 5-fluorocytosine, itraconazole and fluconazole in the treatment of experimental cryptococcosis in mice, was carried out. Seventy male Balb C mice were inoculated intraperitoneally with 10(7) cells of Cryptococcus neoformans var. neoformans. They were divided in 7 groups of 10 animals each one: 1) treated with fluconazole by gavage at a daily dose of 16 mg/kg; 2) treated with itraconazole by gavage at a daily dose of 16 mg/kg; 3) treated with 5-fluorocytosine by gavage at a daily dose of 300 mg/kg; 4) treated with amphotericin B intraperitoneally at a dose of 6 mg/kg every other day; 5) control animals receiving polietilenglicol 200 by gavage; 6) control animals receiving distilled water by gavage and 7) control animals receiving sterile distilled water by intraperitoneal route. All the treatments started 5 days after the challenge inoculation and they were given for 2 weeks. The following parameters were taken into account: survival time, macroscopic aspect of the organ after the complete autopsy, microscopic investigation of yeasts in brain, lungs, spleen and liver, histopathology studies of these organs, the colony forming units per gram and massive seeding of brain and lungs. The survival index of the different groups was the most efficient method to measure the antifungal compounds activity. Amphotericin B increased significantly the animals survival and modified the histopathologic response in the studied organs. The colony forming units and the massive seeding in brain and lung showed that this antifungal agent is unable of producing the biological cure of this experimental model.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2594050     DOI: 10.1007/bf00436057

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  9 in total

Review 1.  Acquired immunodeficiency syndrome.

Authors:  R W Wood; A Collier
Journal:  Infect Dis Clin North Am       Date:  1987-03       Impact factor: 5.982

2.  A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis.

Authors:  J E Bennett; W E Dismukes; R J Duma; G Medoff; M A Sande; H Gallis; J Leonard; B T Fields; M Bradshaw; H Haywood; Z A McGee; T R Cate; C G Cobbs; J F Warner; D W Alling
Journal:  N Engl J Med       Date:  1979-07-19       Impact factor: 91.245

3.  In vitro studies with R 51,211 (itraconazole).

Authors:  A Espinel-Ingroff; S Shadomy; R J Gebhart
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

4.  [Experimental subacute cryptococcosis in Wistar rats].

Authors:  R Negroni; J L Finquelievich
Journal:  Medicina (B Aires)       Date:  1987       Impact factor: 0.653

5.  Treatment of experimental sub-acute cryptococcosis in the Wistar rat.

Authors:  J L Finquelievich; R Negroni; A J Bava; C Iovannitti
Journal:  Medicina (B Aires)       Date:  1988       Impact factor: 0.653

Review 6.  Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models.

Authors:  J Van Cutsem; F Van Gerven; P A Janssen
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

7.  Degenerative changes in fungi after itraconazole treatment.

Authors:  M Borgers; M A Van de Ven
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

8.  High-dose ketoconazole for treatment of fungal infections of the central nervous system.

Authors:  P C Craven; J R Graybill; J H Jorgensen; W E Dismukes; B E Levine
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

9.  R 51211 (itraconazole) therapy of murine cryptococcosis.

Authors:  J R Graybill; J Ahrens
Journal:  Sabouraudia       Date:  1984
  9 in total
  1 in total

1.  Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.

Authors:  A J Bava; R Negroni
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.